ZURICH, Nov 11 (Reuters) - Switzerland now has reserved
around 16 million doses of potential COVID-19 vaccines, the
government said on Wednesday, after announcing a 3.2
million-dose reservation with a World Health Organization-led
program and another 3 million-dose pact with Pfizer and
BioNTech.
Switzerland previously reserved nearly 10 million doses of
prospective vaccines from Moderna and AstraZeneca
and has set aside 400 million Swiss francs ($435.92
million) for purchases.
($1 = 0.9176 Swiss francs)
(Reporting by John Miller; editing by Brenna Hughes Neghaiwi)